Li-Ping Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Li-Ping Liu has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Charles M. Deber
Division of Molecular Structure & Function, Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada M5G 1X8
2 shared publications Anthony E. Pegg
Department of Cellular and Molecular Physiology, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033, and Department of Biochemistry and Center in Molecular Toxicology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232
1 shared publication- Chen Wang
Peking University China–Japan Friendship School of Clinical Medicine, Beijing, China
1 shared publication Dingyuan Liang
School of Space and Environment, Beihang University, No. 37, XueYuan Road, HaiDian District, Beijing 100191, PR China
1 shared publication- Frederick Peter Guengerich
Department of Biochemistry, Vanderbilt University School of Medicine
1 shared publication - Kevin M. Williams
Department of Chemistry, Western Kentucky University, Bowling Green, KY, USA
1 shared publication
Latest Publications
- 2 December 2005
- Published by Springer Nature
- p. 124-125
Interplay of hydrophobicity and electrostatics in peptide-bilayer interactions
- 2 December 2005
- Published by Springer Nature
- p. 124-125
Interplay of hydrophobicity and electrostatics in peptide-bilayer interactions
- 2 December 2005
- Published by Springer Nature
- p. 355-357
Prediction of protein transmembrane segments using a hydrophobicity scale derived from hydrophobic peptides
- 2 December 2005
- Published by Springer Nature
- p. 355-357
Prediction of protein transmembrane segments using a hydrophobicity scale derived from hydrophobic peptides
- 5 May 2004
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 17 (6) , 742-752
O 6-Alkylguanine-DNA Alkyltransferase Has Opposing Effects in Modulating the Genotoxicity of Dibromomethane and Bromomethyl Acetate
O6-Alkylguanine-DNA alkyltransferase (AGT) is a DNA repair protein that removes O6-alkylguanine adducts. The interaction of dibromomethane (CH2Br2) and bromomethyl acetate (BrCH2OAc) with AGT was studied in vitro, and the effect of AGT on their toxicity and mutagenicity was investigated using Escherichia coli strain TRG8 (lacking endogenous AGT) that expressed human AGT or its inactive C145A mutant. Both CH2Br2 and BrCH2OAc reacted with AGT at its cysteine acceptor site, abolishing its DNA repair activity with the latter agent being much more potent. The formation of AGT-Cys145S-CH2OAc by BrCH2OAc was confirmed by mass spectral analysis, but the presumed AGT-Cys145S-CH2Br adduct from CH2Br2 was too unstable for such characterization. In the presence of CH2Br2, AGT was covalently cross-linked to an oligodeoxyribonucleotide, 5‘-d(AG)8-3‘, but no cross-link was formed by BrCH2OAc. Survival of cells exposed to CH2Br2 was reduced, and the number of mutants was greatly increased when wild-type AGT was present. The cytotoxicity of CH2Br2 was similar to that of BrCH2CH2Br2, but the mutagenicity was about four times less. Virtually all of the AGT-mediated mutants induced by CH2Br2 in the rpoB gene were at G:C sites with equal numbers of transitions to A:T and transversions to T:A. In contrast, BrCH2OAc was more than 10-fold less genotoxic than CH2Br2 and the survival of cells exposed to BrCH2OAc was not affected by AGT. The number of mutations (almost all G:C to A:T transitions) induced by BrCH2OAc was slightly reduced by the presence of wild-type AGT and substantially increased by the inactive C145A mutant. These results with CH2Br2 are consistent with a mechanism in which reaction at the active site Cys145 residue followed by attack of AGT-Cys145S-CH2Br at guanine in DNA forms a covalent adduct, which leads to cytotoxicity and to mutagenicity. The results with BrCH2OAc suggest that it reacts directly with DNA to form O6-(CH2OAc)guanine, which, if unrepaired, causes G:C to A:T transitions. Our experiments reveal two novel pathways (direct inactivation of AGT and formation of AGT-Cys145S-CH2-DNA adducts) by which CH2Br2 may cause damage to the genome in addition to the well-recognized pathway involving activation by GSTs.
- 5 May 2004
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 17 (6) , 742-752
O 6-Alkylguanine-DNA Alkyltransferase Has Opposing Effects in Modulating the Genotoxicity of Dibromomethane and Bromomethyl Acetate
O6-Alkylguanine-DNA alkyltransferase (AGT) is a DNA repair protein that removes O6-alkylguanine adducts. The interaction of dibromomethane (CH2Br2) and bromomethyl acetate (BrCH2OAc) with AGT was studied in vitro, and the effect of AGT on their toxicity and mutagenicity was investigated using Escherichia coli strain TRG8 (lacking endogenous AGT) that expressed human AGT or its inactive C145A mutant. Both CH2Br2 and BrCH2OAc reacted with AGT at its cysteine acceptor site, abolishing its DNA repair activity with the latter agent being much more potent. The formation of AGT-Cys145S-CH2OAc by BrCH2OAc was confirmed by mass spectral analysis, but the presumed AGT-Cys145S-CH2Br adduct from CH2Br2 was too unstable for such characterization. In the presence of CH2Br2, AGT was covalently cross-linked to an oligodeoxyribonucleotide, 5‘-d(AG)8-3‘, but no cross-link was formed by BrCH2OAc. Survival of cells exposed to CH2Br2 was reduced, and the number of mutants was greatly increased when wild-type AGT was present. The cytotoxicity of CH2Br2 was similar to that of BrCH2CH2Br2, but the mutagenicity was about four times less. Virtually all of the AGT-mediated mutants induced by CH2Br2 in the rpoB gene were at G:C sites with equal numbers of transitions to A:T and transversions to T:A. In contrast, BrCH2OAc was more than 10-fold less genotoxic than CH2Br2 and the survival of cells exposed to BrCH2OAc was not affected by AGT. The number of mutations (almost all G:C to A:T transitions) induced by BrCH2OAc was slightly reduced by the presence of wild-type AGT and substantially increased by the inactive C145A mutant. These results with CH2Br2 are consistent with a mechanism in which reaction at the active site Cys145 residue followed by attack of AGT-Cys145S-CH2Br at guanine in DNA forms a covalent adduct, which leads to cytotoxicity and to mutagenicity. The results with BrCH2OAc suggest that it reacts directly with DNA to form O6-(CH2OAc)guanine, which, if unrepaired, causes G:C to A:T transitions. Our experiments reveal two novel pathways (direct inactivation of AGT and formation of AGT-Cys145S-CH2-DNA adducts) by which CH2Br2 may cause damage to the genome in addition to the well-recognized pathway involving activation by GSTs.